This Article
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Majeska, R. J.
Right arrow Articles by Einhorn, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Majeska, R. J.
Right arrow Articles by Einhorn, T. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?

The Journal of Bone and Joint Surgery, Vol 76, Issue 5 713-721, Copyright © 1994 by Journal of Bone and Joint Surgery, Inc


JOURNAL CONTENTS

Direct modulation of osteoblastic activity with estrogen

RJ Majeska, JT Ryaby and TA Einhorn
Department of Orthopaedics, Mount Sinai School of Medicine, New York, N.Y. 10029-6574.

Estrogens play an important but poorly understood role in the maintenance of skeletal mass. Whereas the mechanisms of estrogen action on bone may be complex, the finding that osteoblasts express estrogen receptors suggests that this class of hormones exerts direct effects on bone cells. To understand how estrogens regulate osteoblastic function, the physiologically active estrogen metabolite 17 beta-estradiol was tested to determine its effects on the well characterized murine osteoblastic cell-line MC3T3-E1. Experiments were designed to identify the effects of estrogen on osteoblastic activities associated with both the formation and the resorption of bone. Estrogen treatment coordinately increased DNA content and alkaline phosphatase activity in MC3T3-E1 cells as much as twofold. The stimulatory effect on alkaline phosphatase was stereospecific, dose-dependent between 0.1 and ten nanomolar, and dependent on the time in culture when the hormone was administered. The effect was also persistent, since alkaline phosphatase activity remained elevated for several days after withdrawal of the hormone. Estrogen increased the levels of messenger RNA for alkaline phosphatase and type-I collagen as well, and these effects also persisted after removal of the hormone. The levels of messenger RNA for osteopontin, another bone-matrix protein, were only slightly affected by estrogen. Finally, estrogen inhibited the activation of adenylate cyclase by three osteotropic agents known to stimulate the resorption of bone: parathyroid hormone, prostaglandin E2, and the beta-adrenergic agonist isoproterenol. Thus, estrogen promoted the expression of traits associated with the formation of bone while reducing cellular responsiveness to hormones that may trigger the resorption of bone.(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Am Acad Orthop SurgHome page
S. B. Goodman, W. Jiranek, E. Petrow, and A. W. Yasko
The Effects of Medications on Bone
J. Am. Acad. Ortho. Surg., August 1, 2007; 15(8): 450 - 460.
[Abstract] [Full Text] [PDF]


Home page
J Am Acad Orthop SurgHome page
H. V. Lochner and T. A. Einhorn
Hormone Replacement Therapy
J. Am. Acad. Ortho. Surg., September 1, 2004; 12(5): 291 - 294.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Khosla, B. L. Riggs, E. J. Atkinson, A. L. Oberg, C. Mavilia, F. Del Monte, L. J. Melton III, and M. L. Brandi
Relationship of Estrogen Receptor Genotypes to Bone Mineral Density and to Rates of Bone Loss in Men
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1808 - 1816.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. A.A. Ewies, F. Al-Azzawi, and J. Thompson
Changes in extracellular matrix proteins in the cardinal ligaments of post-menopausal women with or without prolapse: a computerized immunohistomorphometric analysis
Hum. Reprod., October 1, 2003; 18(10): 2189 - 2195.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. E. Compston
Sex Steroids and Bone
Physiol Rev, January 1, 2001; 81(1): 419 - 447.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Gohel, M.-B. McCarthy, and G. Gronowicz
Estrogen Prevents Glucocorticoid-Induced Apoptosis in Osteoblasts in Vivo and in Vitro
Endocrinology, November 1, 1999; 140(11): 5339 - 5347.
[Abstract] [Full Text]


Home page
Am J Sports MedHome page
S. H. Liu, R. A. Al-Shaikh, V. Panossian, G. A. M. Finerman, and J. M. Lane
Estrogen Affects the Cellular Metabolism of the Anterior Cruciate Ligament: A Potential Explanation for Female Athletic Injury
Am. J. Sports Med., September 1, 1997; 25(5): 704 - 709.
[Abstract] [PDF]


Home page
JBJSHome page
K. HIRAKAWA, T. W. BAUER, B. N. STULBERG, A. H. WILDE, and M. SECIC
Characterization and Comparison of Wear Debris from Failed Total Hip Implants of Different Types
J. Bone Joint Surg. Am., August 1, 1996; 78(8): 1235 - 43.
[Abstract] [Full Text]